About

Kym co-founded one of the first site management organizations in the United States, where she built the systems that turned research physicians ran as a sideline into a repeatable enrollment process. In the UK she ran operations for a network of more than 150 GPs, where her enrollment processes completed studies in six weeks that were taking nine months in other countries.

She later became chief executive of a clinical research company that was facing insolvency, and took it through its IPO. In 2016 she was named EY UK Life Sciences Entrepreneur of the Year and won a Gold Stevie Award as Female Executive of the Year for Europe, the Middle East and Africa.

Since then, early-stage life science companies have brought her in to build them from the inside, as acting chief executive, chief business officer or chair, in fields as far apart as AI-designed vaccines, early cancer detection and lab-grown bile duct replacements. Whatever the role, the question at the center has been the same: how to design a study and reach its patients so it enrolls on time.

Liam is a former professional footballer who trained as a psychologist, and he brings behavioral science and systems thinking to the way a study enrolls. He has run site management organizations, CROs and clinical trial technology companies.

At one company he was brought in to build patient recruitment. He put recruitment and screening into a single process, added an operational intelligence team that tracked every project in real time so problems were fixed before they grew, and industrialized a single site until it handled more than 85,000 leads and 25,500 clinic appointments a year without losing quality. On-time enrollment improved by 59%, to an average of about 97% over seven years, and the same systems took studies from contract signature to database lock in nine months.

Since 2018 he has worked inside CROs, site management organizations and clinical trial technology companies as a fractional executive, rebuilding how they sell, operate and deliver, and helping design platforms for remote trial monitoring, patient recruitment and genetic testing in trials. Every operation he has built was designed around speed of delivery, and that has always come down to reaching the right patients and enrolling them on time.